Blog
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
EQS-News: DEFENCE THERAPEUTICS INITIATES LUNG CANCER TREATMENT PROGRAM WITH ITS NOVEL ACCUTOXTM FORMULATION VIA INTRANASAL
EQS-News: DEFENCE THERAPEUTICS INITIATES LUNG CANCER TREATMENT PROGRAM WITH ITS NOVEL ACCUTOXTM FORMULATION VIA INTRANASAL
EQS-Adhoc: CENIT appoints Axelle Mazé as CFO
EQS-Adhoc: CENIT appoints Axelle Mazé as CFO
EQS-News: Nordex SE: Nordex Group receives order for 95 MW in Spain
EQS-News: Nordex SE: Nordex Group receives order for 95 MW in Spain
EQS-News: Steinhoff International Holdings N.V. : OPERATIONAL UPDATE
EQS-News: Steinhoff International Holdings N.V. : OPERATIONAL UPDATE
EQS-News: AUTO1 Group SE: AUTO1 Group sells 163,500 units in Q3 2022
EQS-News: AUTO1 Group SE: AUTO1 Group sells 163,500 units in Q3 2022
Press release: Leonteq statement on recent media article and business update
Press release: Leonteq statement on recent media article and business update
GI Genius™ named to FORTUNE 2022 “Change the World” list
GI Genius™ named to FORTUNE 2022 “Change the World” list
EQS-News: Gerresheimer AG: Gerresheimer reports double digit growth in revenue and earnings for the third quarter
EQS-News: Gerresheimer AG: Gerresheimer reports double digit growth in revenue and earnings for the third quarter
Sales for the third quarter of 2022 Ad hoc announcement pursuant to Art. 53 LR
Sales for the third quarter of 2022
Ad hoc announcement pursuant to Art. 53 LR
Fuller, Smith & Turner PLC: Transaction in Own Shares
Fuller, Smith & Turner PLC: Transaction in Own Shares
Rights and Issues Investment Trust PLC: Holding(s) in Company*
Rights and Issues Investment Trust PLC: Holding(s) in Company*
EQS-Adhoc: Klöckner & Co SE: Operating income in third quarter 2022 lower than expected due to negative market effects and adjustment of full-year 2022 guidance
EQS-Adhoc: Klöckner & Co SE: Operating income in third quarter 2022 lower than expected due to negative market effects and adjustment of full-year 2022 guidance
INFICON to Publish its Third Quarter 2022 Results on Thursday, October 20, 2022
INFICON to Publish its Third Quarter 2022 Results on Thursday, October 20, 2022
Invitation to Q3 2022 Trading Update Conference Call
Invitation to Q3 2022 Trading Update Conference Call
EQS-News: Abivax: first US patient enrolled in global phase 3 program with obefazimod in ulcerative colitis
EQS-News: Abivax: first US patient enrolled in global phase 3 program with obefazimod in ulcerative colitis
Rights and Issues Investment Trust PLC: Transaction in Own Shares
Rights and Issues Investment Trust PLC: Transaction in Own Shares
Director/PDMR Shareholding
Director/PDMR Shareholding
EQS-News: Bilfinger SE: Share Buyback
EQS-News: Bilfinger SE: Share Buyback
EQS-News: HELMA Eigenheimbau AG provides update on holiday property projects
EQS-News: HELMA Eigenheimbau AG provides update on holiday property projects
Form 8.3 - The Vanguard Group, Inc.: Nektar Therapeutics, Inc
Form 8.3 - The Vanguard Group, Inc.: Nektar Therapeutics, Inc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
Form 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
EQS-News: Eckert & Ziegler to Build Production Line for NorthStar Medical Radioisotopes’ Dedicated Actinium-225 Production Facility
EQS-News: Eckert & Ziegler to Build Production Line for NorthStar Medical Radioisotopes’ Dedicated Actinium-225 Production Facility


